X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

FHTX

Closed

Foghorn Therapeutics inc

4.87
+0.17 (+3.62%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.7
Day's Range: 4.67 - 5.19
Send
When Written:
 
6.2
Foghorn Therapeutics Inc. is a biotechnology company that was founded in 2016 and is based in Cambridge, Massachusetts. The company is focused on developing therapies for cancer and other diseases by targeting the chromatin regulatory system, which controls gene expression. Foghorn's proprietary Gene Traffic Control platform enables the identification of novel drug targets and the development of small molecule drugs that modulate the chromatin regulatory system. The company's lead drug candidate, FHD-286, is currently in preclinical development for the treatment of various cancers. Foghorn has raised over $130 million in funding from investors such as Flagship Pioneering, Polaris Partners, and GV (formerly Google Ventures).

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X